Zoll Medical pledges to share defibrillator data; Danaher Q4 earnings soar;

 @FierceMedDev: Medtronic launches large-scale neurostimulation trial. Item | Follow @FierceMedDev

 @MarkHFierce: BSX will cut as many as 1,000 additional jobs beyond 2011 restructuring--first disclosed in today's Q4 announcement. Release | Follow@MarkHFierce

 @DamianFierce: Next in the Bausch + Lomb saga: Either it's going for an IPO or this is a gambit to pressure buyers. News | Follow @DamianFierce

> Zoll Medical claims to be the first defibrillator manufacturer to publicly pledge that it will share patient data to reduce preventable deaths. Release

> Danaher ($DHR) said it generated $630.4 million in net earnings for its 2012 fourth quarter, 12.5% higher than in the same period in 2011. Release

> Tyrx, a FierceMedicalDevices Fierce 15 company, nailed down an $8.5 million senior secured credit facility to help support, in part, commercialization efforts for its anti-microbial envelope designed to reduce infections for implants like pacemakers. Item

> Argo Medical Technologies is rolling out a next-generation version of an exoskeleton that helps patients with spinal cord injuries walk again. Item

> Ariosa Diagnostics is touting a new study that points to noninvasive prenatal testing with cell-free DNA in high-risk women as both beneficially clinically and cost-effective. Release

> An international study concludes that a new magnesium-based bioabsorbable stent was both safe and effective after a year. Item

> Canadian researchers have determined that an artificial pancreas helps manage Type 1 diabetes a lot better than a traditional insulin pump. Story

> Tom Gentile, president and CEO of GE Healthcare, says his company supports the Affordable Care Act but that the medical device tax will cost "tens of millions of dollars." Item

Biotech News

 @FierceBiotech: Genentech plucks rights to Afraxis drug assets in $187M deal. News | Follow @FierceBiotech

 @JohnCFierce: Big Biotech throwing up state legislative roadblocks against biosimilars, from Pollack at the NYTMore | Follow @JohnCFierce

 @RyanMFierce: Biotech billionaire Soon-Shiong unveils 'convergence' cancer drug startup... Why it's unique? Tech convergence. News | Follow @RyanMFierce

> Pfizer on track to chop R&D budget back to $6.5B-$7B range. Story

> Bristol-Myers dumps rights to Lilly's troubled PhIII Erbitux successor. News

> Amgen, Genentech push blockbuster protection bills in states. Article

Pharma News

 @FiercePharma: Another Hospira recall: Electrolyte solution, after customer complained of mold. No reported injuries. More | Follow @FiercePharma

 @AlisonBFierce: DARPA produced 10 million H1N1 flu vaccine doses in a month. DARPA, Medicago are using tobacco plants instead of eggs. News | Follow @AlisonBFierce

 @EricPFierce: Sartorius Stedim nabs top LEED designation for Puerto Rico plant that recycles AC condensation, uses solar power. Article | Follow@EricPFierce

> Fighting the $9B ghost of Lipitor past, Pfizer points to new drugs. Report

> Lilly sales and profits slide, but analysts expected worse. Article

Pharma Manufacturing News

> Hospira recalls product that may contain mold. News

> EU drugmakers say expect a year from OK to warehouse for new labels. Item

> FDA alleges 3 made millions off scam wholesaler. Story

> Sartorius PR plant first to get LEED's top rating. Article

Biotech Research News

> Addex approaches the clinic for rare dystonias. Article

> Orexo, AstraZeneca join forces against respiratory disease. Item

> Beta blockers could improve cancer treatment in stressed patients. News

> Stem cells help rats recover from stroke. Story

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.